A Study of IDRX-42 (GSK6042981) versus (vs) sunitinib in Participants with Gastrointestinal Stromal Tumors after imatinib Therapy

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2025
This article has no abstract
Epistemonikos ID: 6f50812afd85b2a05c5c1a8a5e8a3261a17a5eb5
First added on: Apr 23, 2026